Roswell Park Explores Stress Receptors as Possible Immune Checkpoint, Suggesting Role for Beta-Blockers in Cancer Treatment

New Orleans, Louisiana (PRWEB) April 09, 2022 -- Combining a beta-blocker with the cancer immunotherapy drug pembrolizumab could be a promising new treatment

Related Keywords

New York ,United States ,American ,Elizabeth Repasky ,Roswell Park ,Benjamin Switzer ,Shipra Gandhi ,Roswell Park Comprehensive Cancer Center ,American Association For Cancer Research ,National Cancer ,Research Award ,Roswell Park Alliance Foundation ,American Association ,Cancer Research ,Annual Meeting ,Assistant Professor ,William Huebsch Professor ,Vice Chair ,Park Comprehensive Cancer Center ,National Cancer Institute Designated ,Upstate New ,Press Release ,